DANOMED ApS: Financial statements 2012
CVR: 29827400
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
DANOMED ApS (CVR 29827400) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -40,168 and a net result of DKK -40,169. Equity in the 2012 report amounted to DKK 873,761. The solvency ratio was 77.1%.
- Gross Profit
- DKK -40,168
- Profit/Loss
- DKK -40,169
- Equity
- DKK 873,761
- Total Assets
- DKK 1,133,404
Official annual report
Keep an eye on DANOMED ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of September 18, 2012, ANKJÆR-JENSEN, STATSAUTORISEREDE REVISORER A/S has been appointed auditor of DANOMED ApS.
As of September 18, 2012, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of DANOMED ApS.
On September 18, 2012, the company changed its name from E.B. INVEST ApS to DANOMED ApS.
About DANOMED ApS
DANOMED ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2006. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named E.B. INVEST ApS. The management consists of Kristian Guldberg Bøje. The company is owned by KGB Invest ApS, Ravimi Holding ApS and Vimira Holding ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 2,342,335 and a net result of DKK -763,540 compared with DKK 1,077,650 the year before. Equity in the 2025 report amounted to DKK 1,322,418.